Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer

PURPOSE: Anti-human epidermal growth factor receptor 2 (HER2) therapies are associated with interstitial lung disease (ILD), also referred to as pneumonitis. In this literature review, we describe the incidence of ILD among patients with HER2-positive metastatic breast cancer (MBC) receiving anti-HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackshaw, Michelle D., Danysh, Heather E., Singh, Jasmeet, Ritchey, Mary E., Ladner, Amy, Taitt, Corina, Camidge, D. Ross, Iwata, Hiroji, Powell, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376509/
https://www.ncbi.nlm.nih.gov/pubmed/32591987
http://dx.doi.org/10.1007/s10549-020-05754-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376509/
https://www.ncbi.nlm.nih.gov/pubmed/32591987
http://dx.doi.org/10.1007/s10549-020-05754-8

Ejemplares similares